Table 2

Patient flow

Budesonide/formoterolBudesonideFormoterolPlaceboTotal
Patients randomised208198201205812
Patients discontinued after randomisation#59 (28)***62 (31)*64 (32)*90 (44)275
Patients discontinued due to COPD deterioration#20 (10)***23 (12)*29 (14)*43 (21)115
Patients discontinued due to AEs other than COPD deterioration16 (8)13 (7)12 (6)17 (8)58
Patients completing study149 (72)136 (69)137 (68)115 (56)537
  • Data are presented as n (%) unless otherwise stated

  • *: p<0.05

  • ***: p<0.001 versus placebo

  • #: Cox regression model